| Intravenous MSC Therapy on Ischemia-Reperfusion Injury in Patients With Myocardial Infarction (NCT03533153) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2021-03-01 |
| Clinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal Naloxone (NCT04764630) | Food and Drug Administration (FDA) | 2021-03-01 |
| A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring (NCT04290182) | Karolinska University Hospital | 2021-03-01 |
| Cannabidiol in Patients With Heart Failure Failure in AHA/ACC Stages A-C (NCT03634189) | Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud | 2021-03-01 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GB1211 in Participants With Suspected or Confirmed Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis (NCT04607655) | Galecto Biotech AB | 2021-03-01 |
| Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer (NCT04781413) | Ruijin Hospital | 2021-03-01 |
| Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers (NCT04464967) | NKGen Biotech, Inc. | 2021-03-01 |
| Alpelisib and Capecitabine in Patients With PIK3CA Mutant mCRC Patients (NCT04753203) | Korean Cancer Study Group | 2021-02-28 |
| Study Investigating Safety,Tolerability,Pharmacokinetics and Antitumor Activities of HBM4003 Combine With Toripalimab (NCT04727164) | Harbour BioMed (Guangzhou) Co. Ltd. | 2021-02-28 |
| A Study of HMPL-306 in Advanced Solid Tumors With IDH Mutations (NCT04762602) | Hutchmed | 2021-02-28 |
| Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Feeding Conditions (NCT04751318) | Laboratorios Andromaco S.A. | 2021-02-27 |
| Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects (NCT05265676) | Venus Remedies Limited | 2021-02-26 |
| Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube (NCT04776135) | Shionogi | 2021-02-26 |
| Safety and Efficacy of 9MW0813 in Subjects With Diabetic Macular Edema (NCT05324592) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2021-02-26 |
| Study of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inclisiran in Chinese Participants With Elevated Serum LDL-C (NCT04774003) | Novartis Pharmaceuticals | 2021-02-26 |
| Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers (NCT04725175) | Contineum Therapeutics | 2021-02-26 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ION904 (NCT04731623) | Ionis Pharmaceuticals, Inc. | 2021-02-26 |
| Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects (NCT04676893) | Chong Kun Dang Pharmaceutical | 2021-02-26 |
| Safety Study of PTP-001 for Treating Knee Osteoarthritis (NCT04632966) | Bioventus LLC | 2021-02-26 |
| SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects (NCT05476107) | Applied Molecular Transport | 2021-02-26 |
| Study of the Excretion of Orally Administered Corticosteroids for the Improval of the Detection of Said Substances in Anti-doping Controls (NCT04791345) | Parc de Salut Mar | 2021-02-26 |
| PTG-100 for Patients With Celiac Disease (NCT04524221) | Nielsen Fernandez-Becker | 2021-02-26 |
| Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT04300140) | Aravive, Inc. | 2021-02-26 |
| A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors (NCT04725331) | Transgene | 2021-02-25 |
| CDK4/6 Tumor, Abemaciclib, Paclitaxel (NCT04594005) | Yonsei University | 2021-02-25 |
| CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL (NCT05270772) | Chinese PLA General Hospital | 2021-02-25 |
| Study to Assess the Bioequivalence of Acalabrutinib Tablet and Acalabrutinib Capsule (NCT04768985) | AstraZeneca | 2021-02-25 |
| The Safety and Pharmacokinetics Preliminary Efficacy of IMP7068 in Patients With Advanced Solid Tumors (NCT04768868) | Impact Therapeutics, Inc. | 2021-02-25 |
| Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition (NCT04542291) | Washington University School of Medicine | 2021-02-25 |
| Multimodal Imaging Outcome Measures for ALS (Image ALS) (NCT04490096) | University of Pennsylvania | 2021-02-25 |
| Post Operative Delirium Study (NCT04635774) | University of Kansas Medical Center | 2021-02-25 |
| Safety and Immunogenicity of COVID-eVax, a Candidate Plasmid DNA Vaccine for COVID-19, in Healthy Adult Volunteers (NCT04788459) | Takis | 2021-02-25 |
| Pharmacokinetics of XNW4107 in Subjects With Various Degrees of Renal Function (NCT04787562) | Evopoint Biosciences Inc. | 2021-02-25 |
| Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study) (NCT04679909) | Altimmune, Inc. | 2021-02-25 |
| A Study of Tilvestamab (BGB149) in Relapsed, Platinum-resistant, High-grade Serous Ovarian Cancer (HGSOC) Participants (NCT04893551) | BerGenBio ASA | 2021-02-25 |
| A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects (NCT05862974) | Luye Pharma Group Ltd. | 2021-02-25 |
| A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NCT04657224) | Janssen Research & Development, LLC | 2021-02-25 |
| A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (NCT04501614) | Takeda | 2021-02-24 |
| A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD) (NCT04184882) | Astellas Pharma Inc | 2021-02-24 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Fatty Liver Disease (NCT04766476) | Bristol-Myers Squibb | 2021-02-24 |
| A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea. (NCT04746105) | Taisho Pharmaceutical Co., Ltd. | 2021-02-24 |
| Safety and Efficacy Evaluation of Bosutinib Plus Atezolizumab in Newly Diagnosed Chronic Leukemia Adult Patients (NCT04793399) | Fundacion Espanola para la Curacion de la Leucemia Mieloide Cronica | 2021-02-24 |
| Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura (NCT04323748) | New York Medical College | 2021-02-24 |
| MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer (NCT04762199) | Emory University | 2021-02-24 |
| Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma (NCT04696731) | Allogene Therapeutics | 2021-02-24 |
| Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients (NCT04839341) | Apollomics Inc. | 2021-02-24 |
| Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder (NCT04294290) | Duke University | 2021-02-24 |
| A Study of LY3410738 in Healthy Adult Participants (NCT06181045) | Eli Lilly and Company | 2021-02-24 |
| An Open Label, Study of the Systemic Exposure to Articaine After Topical Ocular Dosing of AG-920 (NCT04759339) | American Genomics, LLC | 2021-02-24 |
| A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD (NCT04812262) | Neuraly, Inc. | 2021-02-24 |
| Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation (NCT04699188) | Novartis Pharmaceuticals | 2021-02-24 |
| A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma (NCT04674813) | Juno Therapeutics, a Subsidiary of Celgene | 2021-02-24 |
| The Clinical Impact of L-PRF, H-PRF or the Use of Surgical Stent on Palatal Donor Site Healing. (NCT04758702) | Abdo Y Ismail | 2021-02-24 |
| The Efficacy and Safety of CKD516 Combined With Durvalumab in Patient Refractory Solid Tumors (NCT04696848) | Tae Won Kim | 2021-02-24 |
| Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers (NCT05014490) | Darnitsa Pharmaceutical Company | 2021-02-24 |
| COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA (NCT04732468) | ImmunityBio, Inc. | 2021-02-24 |
| Study of Descartes-30 in Acute Respiratory Distress Syndrome (NCT04524962) | Cartesian Therapeutics | 2021-02-23 |
| A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS) (NCT04691141) | Shanghai Antengene Corporation Limited | 2021-02-23 |
| A Trial of SHR-1707 in Healthy Young Adult and Elderly Subjects (NCT04745104) | Atridia Pty Ltd. | 2021-02-23 |
| A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS) (NCT04772885) | Kymera Therapeutics, Inc. | 2021-02-23 |
| Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers (NCT06680856) | Ospedale Policlinico San Martino | 2021-02-23 |
| Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL (NCT04502394) | Kartos Therapeutics, Inc. | 2021-02-23 |
| Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms (NCT04279847) | Incyte Corporation | 2021-02-23 |
| Ntraperitoneal Thermal Perfusion Combined With Chemotherapy Versus Chemotherapy (NCT04707118) | Fudan University | 2021-02-23 |
| The Use of Eculizumab in HELLP Syndrome (NCT04103489) | Johns Hopkins University | 2021-02-23 |
| Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma (NCT04927195) | Evelo Biosciences, Inc. | 2021-02-23 |
| Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules (NCT04675060) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2021-02-23 |
| Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults (NCT04783311) | EuBiologics Co.,Ltd | 2021-02-23 |
| Study to Evaluate the Pharmacokinetics of Tezepelumab in Children With Asthma (NCT04673630) | AstraZeneca | 2021-02-23 |
| Study on the Safety, Tolerance and Pharmacokinetics of Phenlarmide Tablets (NCT04693039) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2021-02-23 |
| Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors (NCT04721015) | AbbVie | 2021-02-23 |
| Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity (NCT04329806) | Italo Biaggioni | 2021-02-23 |
| A Study of Ramucirumab (LY3009806) Given by Injection Under the Skin in Participants With Advanced Cancer (NCT04557384) | Eli Lilly and Company | 2021-02-23 |
| A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer (NCT04633252) | National Cancer Institute (NCI) | 2021-02-23 |
| Nitric Oxide Footbath for Treatment of Diabetic Foot Ulcers (NCT04755647) | Sanotize Research and Development corp. | 2021-02-23 |
| Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects (NCT05095168) | CARE Pharma Shanghai Ltd. | 2021-02-22 |
| Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma (NCT04808037) | Hellenic Society of Hematology | 2021-02-22 |
| Combination GRA and SGLT-2i Treatment in Type 1 Diabetes (NCT04545411) | University of California, San Diego | 2021-02-22 |
| Comparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults. (NCT04673799) | Kunming Pharmaceuticals, Inc. | 2021-02-22 |
| Autologous Ex Vivo Expanded Regulatory T Cells in Ulcerative Colitis (NCT04691232) | University of Erlangen-Nürnberg Medical School | 2021-02-22 |
| Hyperpolarized 129Xe MRI of Survivors of COVID-19 (NCT04659707) | University of Kansas Medical Center | 2021-02-22 |
| Safety Study of Pritumumab in Brain Cancer (NCT04396717) | Nascent Biotech | 2021-02-22 |
| Capivasertib China PK Study (NCT04742036) | AstraZeneca | 2021-02-22 |
| A Study of LY3549492 in Healthy Participants (NCT04758234) | Eli Lilly and Company | 2021-02-22 |
| Investigation of the Effect of Inhibition of CYP3A4/5 by Itraconazole on the PK of CHF6001 (Tanimilast) (NCT04739774) | Chiesi Farmaceutici S.p.A. | 2021-02-22 |
| A Study to Evaluate the Safety and Efficacy of 3% LTX-109 for Nasal Decolonisation of Staphylococcus (NCT04767321) | Pharma Holdings AS | 2021-02-22 |
| A Phase 1 Study of AV-380 in Healthy Subjects (NCT04815551) | AVEO Pharmaceuticals, Inc. | 2021-02-22 |
| Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma. (NCT04688151) | National Health Research Institutes, Taiwan | 2021-02-22 |
| A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma (NCT04696809) | Janssen Pharmaceutical K.K. | 2021-02-22 |
| Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female Subjects (NCT04650542) | HUYABIO International, LLC. | 2021-02-21 |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer (NCT03819296) | M.D. Anderson Cancer Center | 2021-02-21 |
| Study With Heparin Sodium in Intravenous Administration (NCT03125187) | União Química Farmacêutica Nacional S/A | 2021-02-20 |
| Effect of Imatinib in Advance Liver Fibrosis Patients (NCT05224128) | Research Institute for Gastroenterology and Liver Diseases (RIGLD) | 2021-02-20 |
| A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) (NCT04694989) | Chong Kun Dang Pharmaceutical | 2021-02-20 |
| A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression (NCT04573192) | Philogen S.p.A. | 2021-02-19 |
| Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial) (NCT04477512) | Washington University School of Medicine | 2021-02-19 |
| FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae (NCT04759001) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2021-02-18 |
| Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer (NCT04666129) | Sumitomo Pharma America, Inc. | 2021-02-18 |
| Study to Evaluate Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation and Expansion Study of PXS-5505 in Patients With Primary, Post-polycythemia Vera or Post-essential Thrombocythemia Myelofibrosis (NCT04676529) | Syntara | 2021-02-18 |
| Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma (NCT04649073) | Otsuka Pharmaceutical Co., Ltd. | 2021-02-18 |